CLINICAL TRIALS PROFILE FOR DOXYCYCLINE HYCLATE
✉ Email this page to a colleague
All Clinical Trials for DOXYCYCLINE HYCLATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00041977 ↗ | Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea | Completed | CollaGenex Pharmaceuticals | Phase 3 | 2002-06-01 | The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg Tablets, taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea. |
NCT00495313 ↗ | Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens | Completed | CollaGenex Pharmaceuticals | Phase 4 | 2007-03-01 | To compare the safety and efficacy of two treatment regimens: 1) COL-101 and metronidazole gel 1%; 2) Doxycycline hyclate 100 mg and metronidazole gel 1% |
NCT00635609 ↗ | Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate | Completed | Warner Chilcott | Phase 4 | 2008-03-01 | Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DOXYCYCLINE HYCLATE
Condition Name
Clinical Trial Locations for DOXYCYCLINE HYCLATE
Trials by Country
Clinical Trial Progress for DOXYCYCLINE HYCLATE
Clinical Trial Phase
Clinical Trial Sponsors for DOXYCYCLINE HYCLATE
Sponsor Name